What is King Pharmaceuticals's other non-current assets?

King Pharmaceuticals (KG) reported other non-current assets of $17.64M in Q1 2026.

What does other non-current assets mean?

Long-term assets not classified in specific categories — a catch-all for miscellaneous non-current assets.

King Pharmaceuticals KG Other Non-Current Assets

Other Non-Current Assets at other companies

Arch Capital GroupACGL

$6.81B+10.0%

Everest GroupEG

$1.86B+49.8%

SiriusPointSPNT

$251.2M-11.7%

Skyward Specialty Insurance Group, Inc.SKWD

$160.01M+76.7%

Selective Insurance GroupSIGI

$326.73M+16.0%

Tiptree Inc.TIPT

——

Segments

By segment

See full

Legacy Reinsurance$603K—

Other financials

Income statement

See full

Revenue$10.2M+1,112%

Net income-$7.4M-1,786%

EPS (diluted)-$0.96-586%

Balance sheet

See full

Cash & equivalents$62.2M+1,724%

Total debt$176.7M—

Total equity$121.4M+2,773%

Total assets$964.2M—

Cash flow

See full

Operating cash flow-$15.1M-1,628%

Valuation

See full

Market cap$70.42M-67.6%

Enterprise value$184.93M-50.0%

P/E1.2×—

P/S1.6×-24.3×

Profitability

See full

Net margin131.5%—

Returns & leverage

See full

Return on equity90.8%—

Debt / equity1.5×—

Where this comes from

Reported directly by King Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:OtherAssets.

The official record: King Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about King Pharmaceuticals's other non-current assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is King Pharmaceuticals's other non-current assets?: King Pharmaceuticals (KG) reported other non-current assets of $17.64M in Q1 2026.
What does other non-current assets mean?: Long-term assets not classified in specific categories — a catch-all for miscellaneous non-current assets.